- Francis H Sansbury, academic clinical fellow/specialty registrar in clinical genetics1,
- Sian Ellard, professor of human molecular genetics2,
- Charles Shaw-Smith, consultant clinical geneticist1,
- Peter Turnpenny, consultant clinical geneticist1
- 1Peninsula Clinical Genetics Service, and Department of Molecular Genetics, Royal Devon and Exeter NHS Foundation Trust, Royal Devon and Exeter Hospital (Heavitree), Exeter EX1 2ED, UK
- 2University of Exeter Medical School, Royal Devon and Exeter Hospital (Wonford), Exeter EX2 5DW, UK
- fsansbury{at}nhs.net
As Arshad and colleagues point out, some patients with Hirschsprung’s disease will have a family history.1 Many patients will also have an identifiable genetic cause.
For example, RET mutations may account for up to 41% of non-syndromic Hirschsprung’s disease and half of all familial disease. There are further monogenic causes for both non-syndromic and syndromic Hirschsprung’s disease. Syndromic causes include neurofibromatosis type 1, Smith-Lemli-Opitz syndrome, and multiple endocrine neoplasia type 2 (caused by RET mutations), and around 12% have a genetic cause. These include Down’s syndrome, but also several small chromosome deletions.2 It may be helpful for the family and clinicians to know who and whose children are at risk of Hirschsprung’s disease. Your local regional genetics service would be happy to discuss appropriate investigations.
Notes
Cite this as: BMJ 2012;345:e8199
Footnotes
Competing interests: None declared.
References
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.